No Closed Formularies In Medicaid Without Forgoing Rebates, CMS Tells Massachusetts
Executive Summary
US agency decision is a relief to manufacturers worried that the Massachusetts plan would lead to reduced drug access and heavier rebate burdens.
You may also be interested in...
US Medicaid Director Tsai Proposed Closed Formulary As Head Of Massachusetts Medicaid
Tsai will likely participate in a decision on whether to allow Tennessee to move ahead with changes to its Medicaid program that might include the flexibility to exclude drugs from coverage.
Medicaid Programs Should Be Able To ‘Compel’ Value-Based Contracts, State Association Official Says
Existing value-based contracts, which are voluntary for manufacturers, do not lower costs for states, National Association of Medicaid Directors executive director Matt Salo suggests.
Tennessee Medicaid Gets US Approval For Closed Formulary As Part Of ‘Capped’ Spending Program
Demonstration, which may not survive scrutiny from the Biden Administration, includes some protections, such as prohibiting Tennessee from excluding drugs described in the Medicare Part D protected classes policy.